103 related articles for article (PubMed ID: 17714825)
1. Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma.
Melum E; Friman S; Bjøro K; Rasmussen A; Isoniemi H; Gjertsen H; Bäckman L; Oksanen A; Olausson M; Duraj FF; Ericzon BG
J Hepatol; 2007 Dec; 47(6):777-83. PubMed ID: 17714825
[TBL] [Abstract][Full Text] [Related]
2. Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus.
Thuluvath PJ; Maheshwari A; Thuluvath NP; Nguyen GC; Segev DL
Liver Transpl; 2009 Jul; 15(7):754-62. PubMed ID: 19562709
[TBL] [Abstract][Full Text] [Related]
3. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
[TBL] [Abstract][Full Text] [Related]
4. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
Mas VR; Fisher RA; Archer KJ; Yanek KC; Williams B; Dumur CI; Maluf DG
Transplantation; 2007 Apr; 83(7):973-81. PubMed ID: 17460570
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus-related cirrhosis as a significant mortality factor in intention-to-treat analysis in liver transplantation.
Gringeri E; Vitale A; Brolese A; Zanus G; Boccagni P; Neri D; Valmasoni M; D'Amico F; Ciarleglio FA; Carraro A; Pauletto A; Violi P; Bassi D; D'Amico F; D'Amico DF; Cillo U
Transplant Proc; 2007; 39(6):1901-3. PubMed ID: 17692648
[TBL] [Abstract][Full Text] [Related]
6. Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation.
Melum E; Schrumpf E; Bjøro K
Scand J Gastroenterol; 2006 May; 41(5):592-6. PubMed ID: 16638703
[TBL] [Abstract][Full Text] [Related]
7. Outcome of hepatitis C patients with and without hepatocellular carcinoma undergoing liver transplant.
Min AD; Saxena R; Thung SN; Atillasoy EO; Wolf DC; Sauter B; Schwartz ME; Bodenheimer HC
Am J Gastroenterol; 1998 Nov; 93(11):2148-53. PubMed ID: 9820388
[TBL] [Abstract][Full Text] [Related]
8. Minimal but significant improvement in survival for non-hepatitis C-related adult liver transplant patients beyond the one-year posttransplant mark.
McCaughan GW; Shackel NA; Strasser SI; Dilworth P; Tang P;
Liver Transpl; 2010 Feb; 16(2):130-7. PubMed ID: 20104480
[TBL] [Abstract][Full Text] [Related]
9. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
10. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
11. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
Neff GW; O'Brien CB; Nery J; Shire NJ; Nishida S; delaGarza J; Montalbano M; Safdar K; Ruiz P; Rideman E; Gascon JA; Tzakis AG; Madariaga J; Rudich SM
Liver Transpl; 2004 Dec; 10(12):1497-503. PubMed ID: 15558835
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?
Huo TI; Huang YH; Hsia CY; Su CW; Lin HC; Hsu CY; Lee PC; Lui WY; Loong CC; Chiang JH; Chiou YY; Lee SD
Liver Int; 2009 May; 29(5):767-73. PubMed ID: 19018974
[TBL] [Abstract][Full Text] [Related]
13. Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma.
Morinaga S; Tarao K; Yamamoto Y; Nakamura Y; Rino Y; Miyakawa K; Ohkawa S; Akaike M; Sugimasa Y; Takemiya S
J Gastroenterol Hepatol; 2007 Aug; 22(8):1249-55. PubMed ID: 17688665
[TBL] [Abstract][Full Text] [Related]
14. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
15. Outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
Rossi M; Merli M; Lai Q; Gentili F; Mennini G; Bussotti A; Pugliese F; Della Pietra F; Poli L; Novelli G; Giusto M; Ginanni Corradini S; Iappelli M; Onetti Muda A; Di Tondo U; Gossetti F; Attili AF; Berloco PB
Transplant Proc; 2007; 39(6):1895-7. PubMed ID: 17692646
[TBL] [Abstract][Full Text] [Related]
16. Multimodality therapy and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: 6 years, single-center experience.
Maluf DG; Stravitz RT; Williams B; Cotterell AH; Mas VR; Heuman D; Luketic V; Shiffman ML; Sterling R; Posner MP; Fisher RA
Transplant Proc; 2007; 39(1):153-9. PubMed ID: 17275495
[TBL] [Abstract][Full Text] [Related]
17. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
Cuomo O; Perrella A; Arenga G
Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
[TBL] [Abstract][Full Text] [Related]
18. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
19. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
[TBL] [Abstract][Full Text] [Related]
20. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
